Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia

Frontiers in Immunology(2022)10.3389/fimmu.2022.845488Source: DataRank Database

Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.55)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Stephanie M. McGregor ORCID,Sheila Dias ORCID,Mihalis Verykokakis ORCID,Michelle M. Le Beau ORCID,Hai‐Hui Xue ORCID

Live enrichment

PubMed:35371057 PMC:PMC8971981 OpenAlex:https://openalex.org/W4220796204

NCI NIH HHS

Grant: P30 CA014599

NIAID NIH HHS

Grant: R21 AI096530

NIAID NIH HHS

Grant: R21 AI119894

NIAID NIH HHS

Grant: R01 AI079213

National Institutes of Health

FWCI

1.55

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

goldLicense: cc-by

journalhttps://doi.org/10.3389/fimmu.2022.845488

publisherhttps://doi.org/10.3389/fimmu.2022.845488

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.845488/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35371057

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8971981

Fields of Study

Acute Lymphoblastic Leukemia researchImmune Cell Function and InteractionAcute Myeloid Leukemia Research

MeSH Terms

AnimalsOncogenesTranscription FactorsMiceTCF Transcription FactorsLymphoid Enhancer-Binding Factor 1Precursor Cell Lymphoblastic Leukemia-LymphomaPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma

Keywords

EnhancerSuppressorCancer researchBiologyOncogeneTranscription factorMutationLeukemiaGeneT cellImmunologyGeneticsCell cycleImmune systemLymphocyteThymusLef1E2a

Sustainable Development Goals

SDG 0: Partnerships for the goals

Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia

FAIR Checklist

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)